The Patent Finder

Inovio Pharmaceuticals, Inc.

89 patents currently held · Updated Nov 18, 2026
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as VGX Pharmaceuticals, LLC (to 2013)

18
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 19 to 21, 2026 · next Nov 19
  • 1 fee due Dec 27, 2026
    The maintenance fee for Method and device for minimally invasive in vivo transfection of adipose tissue using electroporation (US 11,684,777) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 3 fees due Feb 13 to 18, 2027 · next Feb 13
  • 2 fees due Mar 3 to 5, 2027 · next Mar 3
  • 4 fees due Apr 13 to 30, 2027 · next Apr 13
  • 2 fees due Jun 19 to 26, 2027 · next Jun 19
  • 2 fees due Jul 9 to 30, 2027 · next Jul 9
  • 2 fees due Aug 4 to 13, 2027 · next Aug 4
  • 1 fee due Sep 12, 2027
    The maintenance fee for DNA antibody constructs encoding anti-ZIKV envelope antibodies (US 11,925,685) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Variable current density single needle electroporation system and method (US 10,610,684) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 2 fees due Nov 14, 2027

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,369,359Device and method for single-needle in vivo electroporation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,547,293Triggering mechanism for needle-free injector
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,563,302Optimized high yield synthetic plasmids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,058,253Growth hormone releasing hormone treatment to decrease cholesterol levels
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,846,720Optimized high yield synthetic plasmids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,156,890HCV Vaccines and Methods for Using the Same
In force
 · High confidence
In forceHigh confidence
US 9,156,891Vaccines And Methods For Using The Same
In force
 · High confidence
In forceHigh confidence
US 7,717,874Needle-Free Injection System
In force
 · High confidence
In forceHigh confidence
US 8,617,099Injection device plunger auto-disable
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,376,692Electroporation device and injection apparatus
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 89 patents shown.
Pro members see all 89.
Pro members: see all 89 patents
Also on record, not counted in the 89: 13 patents in force now held by others · 10 lapsed for an unpaid fee · 48 ended at full term · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

36 pending · 13 abandoned · 13 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited